Zobrazeno 1 - 10
of 2 493
pro vyhledávání: '"Liang-In Lin"'
Autor:
Feng-Ming Tien, Chi-Yuan Yao, Xavier Cheng-Hong Tsai, Min-Yen Lo, Chien-Yuan Chen, Wan-Hsuan Lee, Chien-Chin Lin, Yuan-Yeh Kuo, Yen-Ling Peng, Mei-Hsuan Tseng, Yu-Sin Wu, Ming-Chih Liu, Liang-In Lin, Ming-Kai Chuang, Bor-Sheng Ko, Ming Yao, Jih-Luh Tang, Wen-Chien Chou, Hsin-An Hou, Hwei-Fang Tien
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Acute myeloid leukemia (AML) with CEBPA bZIP in-frame mutations (CEBPA bZIP-inf) is classified within the favorable-risk group by the 2022 European LeukemiaNet (ELN-2022). However, heterogeneous clinical outcomes are still observed in these
Externí odkaz:
https://doaj.org/article/a473b9ab2e6e4571988c16d2b5a68bfe
Autor:
Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai, Feng-Ming Tien, Min-Yen Lo, Mei-Hsuan Tseng, Yuan-Yeh Kuo, Ming-Chih Liu, Yi-Tsung Yang, Jui-Che Chen, Jih-Luh Tang, Hsun-I Sun, Yi-Kuang Chuang, Liang-In Lin, Wen-Chien Chou, Chien-Chin Lin, Hsin-An Hou, Hwei-Fang Tien
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Myelodysplastic syndromes (MDS) have varied prognoses and require a risk-adapted treatment strategy for treatment optimization. Recently, a molecular prognostic model (Molecular International Prognostic Scoring System [IPSS-M]) that combines
Externí odkaz:
https://doaj.org/article/7479abc62de646a98b87cad2d66ca5e0
Publikováno v:
HemaSphere, Vol 7, p e796010d (2023)
Externí odkaz:
https://doaj.org/article/556ea1da4d6c4dcaa96f4b8f7cb1e10e
Autor:
Chi-Yang Tseng, Ya-Chu Yu, Chia-Hung Kuo, Kuan-Wei Su, Kam Hoi Ho, Da-Liang Ou, Hsin-An Hou, Liang-In Lin
Publikováno v:
HemaSphere, Vol 7, p e4377164 (2023)
Externí odkaz:
https://doaj.org/article/b5b6a200c5bf4caba24378c50151c78d
Publikováno v:
HemaSphere, Vol 7, p e6210037 (2023)
Externí odkaz:
https://doaj.org/article/07601fb0669c414c982e63ddb1c86188
Autor:
Chi-Yuan Yao, Andreas Agathangelidis, Shih-Sung Chuang, Hsiao-Hui Tsou, Wei-Lien Feng, Ta-Chih Liu, Tsai-Yun Chen, Yuan-Bin Yu, Su-Peng Yeh, Ming Yao, Chuan-Cheng Wang, Johnson Lin, Wen-Li Hwang, Jyh-Pyng Gau, Wen-Chien Chou, Tsu-Yi Chao, Liang-In Lin, Hwei-Fang Tien, Paolo Ghia, Shang-Ju Wu
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e803 (2022)
Asian patientswith chronic lymphocytic leukemia (CLL) exhibit immunoglobulin heavy variable (IGHV) gene repertoires that are distinct from those observed in Western populations, and a higher proportion of Asian CLL patients carry heavy loads of somat
Externí odkaz:
https://doaj.org/article/78c7ab16135747998b44b94ac0983fe5
Autor:
Cheng-Hong Tsai, Chi-Yuan Yao, Feng-Min Tien, Jih-Luh Tang, Yuan-Yeh Kuo, Yu-Chiao Chiu, Chien-Chin Lin, Mei-Hsuan Tseng, Yen-Ling Peng, Ming-Chih Liu, Chia-Wen Liu, Ming Yao, Liang-In Lin, Wen-Chien Chou, Chien-Yu Chen, Hsin-An Hou, Hwei-Fang Tien
Publikováno v:
EBioMedicine, Vol 40, Iss , Pp 240-250 (2019)
Background: Expression of long non-coding RNAs (lncRNAs) has recently been recognized as a potential prognostic marker in acute myeloid leukemia (AML). However, it remains unclear whether incorporation of the lncRNAs expression in the 2017 European L
Externí odkaz:
https://doaj.org/article/9408d3a4d7ab488fb4e6d2b8f6f08a36
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 95 (2022)
The poor prognosis of patients diagnosed with hepatocellular carcinoma (HCC) is directly associated with the multi-step process of tumor metastasis. TWIST1, a basic helix-loop-helix (bHLH) transcription factor, is the most important epithelial-mesenc
Externí odkaz:
https://doaj.org/article/7db9503a94aa410bbf718708f2841e95
Autor:
Ching-Hung Hsieh, Cheng-Zhe Jian, Liang-In Lin, Guan-Sian Low, Ping-Yun Ou, Chiun Hsu, Da-Liang Ou
Publikováno v:
Cancers, Vol 14, Iss 2, p 294 (2022)
Immune checkpoint inhibitors (ICIs), including antibodies that target programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), or cytotoxic T lymphocyte antigen 4 (CTLA4), represent some of the most important breakthroughs in new dr
Externí odkaz:
https://doaj.org/article/fce4a1f6430642e5b276ecb456f6615d
Autor:
Yu-Hsuan Fu, Chi-Yang Tseng, Jeng-Wei Lu, Wen-Hui Lu, Pei-Qi Lan, Chien-Yuan Chen, Da-Liang Ou, Liang-In Lin
Publikováno v:
Biomedicines, Vol 9, Iss 12, p 1869 (2021)
Pyrvinium pamoate, a widely-used anthelmintic agent, reportedly exhibits significant anti-tumor effects in several cancers. However, the efficacy and mechanisms of pyrvinium against myeloid leukemia remain unclear. The growth inhibitory effects of py
Externí odkaz:
https://doaj.org/article/9c8b24e3337a444b99a06965c2eb87d3